Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 95 articles:
HTML format
Text format



Single Articles


    May 2018
  1. NICOLSON NG, Murtha TD, Dong W, Paulsson JO, et al
    Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.
    J Clin Endocrinol Metab. 2018 May 2. pii: 4990776. doi: 10.1210/jc.2018-00277.
    PubMed     Text format     Abstract available


    April 2018
  2. TRAN B DR., Roshan D Mr., Abraham E Dr., Wang L Dr., et al
    An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2018 Apr 16. pii: 4970148. doi: 10.1210/jc.2017-02551.
    PubMed     Text format     Abstract available


    February 2018
  3. WASSERMAN JD, Sabbaghian N, Fahiminiya S, Chami R, et al
    DICER1 mutations are frequent in adolescent-onset papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2018 Feb 21. pii: 4893697. doi: 10.1210/jc.2017-02698.
    PubMed     Text format     Abstract available


  4. SAMUELS SL, Surrey LF, Hawkes CP, Amberge M, et al
    Characteristics of Follicular Variant Papillary Thyroid Carcinoma in a Pediatric Cohort.
    J Clin Endocrinol Metab. 2018 Feb 8. pii: 4844750. doi: 10.1210/jc.2017-02454.
    PubMed     Text format     Abstract available


    January 2018
  5. GIORDANO TJ, Haugen B, Sherman SI, Shah MH, et al
    Pioglitazone Therapy of PAX8-PPARgamma Fusion Protein Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2018 Jan 24. pii: 4822913. doi: 10.1210/jc.2017-02533.
    PubMed     Text format     Abstract available


    December 2017
  6. RITTER A, Bachar G, Hirsch D, Benbassat C, et al
    Natural History of Contralateral Nodules after Lobectomy in Patients with Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2017 Dec 12. pii: 4731740. doi: 10.1210/jc.2017-01616.
    PubMed     Text format     Abstract available


  7. VAN DER TUIN K, Tops CMJ, Adank MA, Cobben JM, et al
    CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2017;102:4534-4540.
    PubMed     Text format     Abstract available


    November 2017
  8. HE H, Li W, Liyanarachchi S, Wang Y, et al
    The role of NRG1 in the predisposition to papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2017 Nov 7. doi: 10.1210/jc.2017-01798.
    PubMed     Text format     Abstract available


  9. MAZZIOTTI G, Formenti AM, Frara S, Olivetti R, et al
    HIGH PREVALENCE OF RADIOLOGICAL VERTEBRAL FRACTURES IN WOMEN ON TSH-SUPPRESSIVE THERAPY FOR THYROID CARCINOMA.
    J Clin Endocrinol Metab. 2017 Nov 7. doi: 10.1210/jc.2017-01986.
    PubMed     Text format     Abstract available


  10. CASEY RT, Warren AY, Martin JE, Challis BG, et al
    Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
    J Clin Endocrinol Metab. 2017;102:4013-4022.
    PubMed     Text format     Abstract available


    October 2017

  11. CORRIGENDUM FOR Letter to the Editor: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness".
    J Clin Endocrinol Metab. 2017 Oct 24. doi: 10.1210/jc.2017-02312.
    PubMed     Text format    


  12. ANGELL TE, Vyas C, Medici M, Wang Z, et al
    Differential Growth Rates of Benign versus Malignant Thyroid Nodules.
    J Clin Endocrinol Metab. 2017 Oct 12. doi: 10.1210/jc.2017-01832.
    PubMed     Text format     Abstract available


  13. PRASONGSOOK N, Kumar A, Chintakuntlawar AV, Foote RL, et al
    Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.
    J Clin Endocrinol Metab. 2017 Oct 5. doi: 10.1210/jc.2017-01180.
    PubMed     Text format     Abstract available


    September 2017
  14. VOSS RK, Grubbs EG
    Response to Letter: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness".
    J Clin Endocrinol Metab. 2017;102:3559.
    PubMed     Text format    


  15. CASTINETTI F, Whollk N
    Letter to the Editor: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness".
    J Clin Endocrinol Metab. 2017;102:3557-3558.
    PubMed     Text format    


  16. COTE GJ, Evers C, Hu MI, Grubbs EG, et al
    Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2017;102:3591-3599.
    PubMed     Text format     Abstract available


  17. VIOLA D, Giani C, Mazzeo S, Ugolini C, et al
    KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.
    J Clin Endocrinol Metab. 2017;102:3091-3096.
    PubMed     Text format     Abstract available


    August 2017
  18. DOS REIS MB, Barros-Filho MC, Marchi FA, Beltrami CM, et al
    Prognostic classifier based on genome-wide DNA methylation profiling in well-differentiated thyroid tumors.
    J Clin Endocrinol Metab. 2017 Aug 16. doi: 10.1210/jc.2017-00881.
    PubMed     Text format     Abstract available


    July 2017
  19. FRENCH JD, Haugen BR
    Thyroid-Specific T Cells in Patients With Differentiated Thyroid Cancer: Implications for Immune-Based Therapies?
    J Clin Endocrinol Metab. 2017;102:2131-2132.
    PubMed     Text format    


    June 2017
  20. SZCZEPANEK-PARULSKA E, Zybek-Kocik A, Wartofsky L, Ruchala M, et al
    Thyroid hemiagenesis: incidence, clinical significance and genetic background.
    J Clin Endocrinol Metab. 2017 Jun 28. doi: 10.1210/jc.2017-00784.
    PubMed     Text format     Abstract available


  21. ROSSFELD KK, Justiniano SE, Ding H, Gong L, et al
    Biological evaluation of a novel fluorescent-imaging agent for medullary thyroid cancer in an orthotopic model.
    J Clin Endocrinol Metab. 2017 Jun 7. doi: 10.1210/jc.2017-00573.
    PubMed     Text format     Abstract available


  22. WANG F, Yu X, Shen X, Zhu G, et al
    The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2017 Jun 5. doi: 10.1210/jc.2017-00277.
    PubMed     Text format     Abstract available


  23. MATHIESEN JS, Habra MA, Bassett JHD, Choudhury SM, et al
    Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    J Clin Endocrinol Metab. 2017;102:2069-2074.
    PubMed     Text format     Abstract available


  24. MOMESSO DP, Tuttle RM
    Response to Letter: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?
    J Clin Endocrinol Metab. 2017;102:2115-2116.
    PubMed     Text format    


  25. GIOVANELLA L, Cosma C, Plebani M
    Letter to the Editor: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?
    J Clin Endocrinol Metab. 2017;102:2113-2114.
    PubMed     Text format    


    May 2017
  26. LEE JJ, Wang TY, Liu CL, Chien MN, et al
    Dipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2017 May 26. doi: 10.1210/jc.2017-00346.
    PubMed     Text format     Abstract available


  27. VOSS RK, Feng L, Lee JE, Perrier ND, et al
    Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness
    J Clin Endocrinol Metab. 2017 May 9. doi: 10.1210/jc.2017-00317.
    PubMed     Text format     Abstract available


  28. IMAIZUMI M, Ohishi W, Nakashima E, Sera N, et al
    Thyroid dysfunction and autoimmune thyroid diseases among atomic-bomb survivors exposed in childhood.
    J Clin Endocrinol Metab. 2017 May 1. doi: 10.1210/jc.2017-00102.
    PubMed     Text format     Abstract available


  29. ELISEI R, Binchi F, Matrone A
    Response to Letter: "Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation".
    J Clin Endocrinol Metab. 2017;102:1785-1786.
    PubMed     Text format    


  30. GIOVANELLA L, Ceriani L, Trimboli P
    Letter to the Editor: "Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation".
    J Clin Endocrinol Metab. 2017;102:1783-1784.
    PubMed     Text format    


    April 2017
  31. PAPALEONTIOU M, Hughes DT, Guo C, Banerjee M, et al
    Population-Based Assessment of Complications following Surgery for Thyroid Cancer.
    J Clin Endocrinol Metab. 2017 Apr 28. doi: 10.1210/jc.2017-00255.
    PubMed     Text format     Abstract available


  32. WASSNER AJ, Della Vecchia M, Jarolim P, Feldman HA, et al
    Prevalence and Significance of Thyroglobulin Antibodies in Pediatric Thyroid Cancer.
    J Clin Endocrinol Metab. 2017 Apr 10. doi: 10.1210/jc.2017-00286.
    PubMed     Text format     Abstract available


    March 2017
  33. CAHOON EK, Nadirov EA, Polanskaya ON, Yauseyenka VV, et al
    Risk of thyroid nodules in residents of Belarus exposed to Chernobyl fallout as children and adolescents.
    J Clin Endocrinol Metab. 2017 Mar 22. doi: 10.1210/jc.2016-3842.
    PubMed     Text format     Abstract available


  34. LUBIN JH, Adams MJ, Shore R, Holmberg E, et al
    Thyroid cancer following childhood low dose radiation exposure: a pooled analysis of nine cohorts.
    J Clin Endocrinol Metab. 2017 Mar 8. doi: 10.1210/jc.2016-3529.
    PubMed     Text format     Abstract available


  35. MELO M, Gaspar da Rocha A, Batista R, Vinagre J, et al
    TERT, BRAF and NRAS in primary thyroid cancer and metastatic disease.
    J Clin Endocrinol Metab. 2017 Mar 6. doi: 10.1210/jc.2016-2785.
    PubMed     Text format     Abstract available


  36. KWON H, Oh HS, Kim M, Park S, et al
    Active Surveillance for Patients with Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
    J Clin Endocrinol Metab. 2017 Mar 3. doi: 10.1210/jc.2016-4026.
    PubMed     Text format     Abstract available


    February 2017
  37. KIM TH, Ki CS, Kim HS, Kim K, et al
    Refining dynamic risk stratification and prognostic groups for differentiated thyroid cancer with TERT promoter mutations.
    J Clin Endocrinol Metab. 2017 Feb 28. doi: 10.1210/jc.2016-3434.
    PubMed     Text format     Abstract available


  38. KHAN NE, Bauer AJ, Schultz KA, Doros L, et al
    Quantification of thyroid cancer and multinodular goiter risk in the DICER1 syndrome: a family-based cohort study.
    J Clin Endocrinol Metab. 2017 Feb 2. doi: 10.1210/jc.2016-2954.
    PubMed     Text format     Abstract available


    January 2017
  39. CHOKSI P, Papaleontiou M, Guo C, Worden F, et al
    Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study.
    J Clin Endocrinol Metab. 2017 Jan 25. doi: 10.1210/jc.2016-3906.
    PubMed     Text format     Abstract available


  40. PARK S, Jeon MJ, Song E, Oh HS, et al
    Clinical Features of Early and Late Postoperative Hypothyroidism after Lobectomy.
    J Clin Endocrinol Metab. 2017 Jan 11. doi: 10.1210/jc.2016-3597.
    PubMed     Text format     Abstract available


    December 2016
  41. NIES M, Klein Hesselink MS, Huizinga GA, Sulkers E, et al
    Long-term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Dec 21:jc20162246. doi: 10.1210/jc.2016-2246.
    PubMed     Text format     Abstract available


  42. BAGHERI-YARMAND R, Williams MD, Grubbs EG, Gagel RF, et al
    ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.
    J Clin Endocrinol Metab. 2016 Dec 9:jc20162878.
    PubMed     Text format     Abstract available


  43. MATRONE A, Gambale C, Piaggi P, Viola D, et al
    Postoperative thyroglobulin and neck ultrasound in the risk re-stratification and decision to perform 131I ablation.
    J Clin Endocrinol Metab. 2016 Dec 8:jc20162860.
    PubMed     Text format     Abstract available


    November 2016
  44. SCHNEIDER TC, de Wit D, Links TP, van Erp NP, et al
    Everolimus in patients with advanced follicular-derived thyroid cancer; results of a phase II clinical trial.
    J Clin Endocrinol Metab. 2016 Nov 21:jc20162525.
    PubMed     Text format     Abstract available


  45. EHLERS M, Kuebart A, Hautzel H, Enczmann J, et al
    Epitope-specific antitumor immunity suppresses tumor spread in papillary thyroid cancer.
    J Clin Endocrinol Metab. 2016 Nov 18:jc20162469.
    PubMed     Text format     Abstract available


  46. MAROTTA V, Sciammarella C, Capasso M, Testori A, et al
    Germline polymorphisms of the VEGF-pathway predict recurrence in non-advanced differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2016 Nov 16:jc20162555.
    PubMed     Text format     Abstract available


  47. SUNG TY, Jeon MJ, Lee YH, Lee YM, et al
    Initial and Dynamic Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2016 Nov 3:jc20162666.
    PubMed     Text format     Abstract available


    October 2016
  48. MOON JH, Kim KM, Oh TJ, Choi SH, et al
    The effect of TSH-suppression on vertebral trabecular bone scores in patients with differentiated thyroid carcinoma.
    J Clin Endocrinol Metab. 2016 Oct 18:jc20162740.
    PubMed     Text format     Abstract available


  49. WANG W, Kang H, Zhao Y, Min I, et al
    Targeting autophagy sensitizes BRAF-mutant thyroid cancer to vemurafenib.
    J Clin Endocrinol Metab. 2016 Oct 18:jc20161999.
    PubMed     Text format     Abstract available


  50. TALLINI G, Tuttle RM, Ghossein RA
    THE HISTORY OF THE FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20162976.
    PubMed     Text format     Abstract available


  51. ZHANG Y, Sui F, Ma J, Ren X, et al
    Positive Feedback Loops between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20161677.
    PubMed     Text format     Abstract available


  52. HWANGBO Y, Kim JM, Park YJ, Lee EK, et al
    Long-term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20162287.
    PubMed     Text format     Abstract available


    September 2016
  53. KAKARMATH S, Heller HT, Alexander CA, Cibas ES, et al
    Clinical, Sonographic, and Pathologic Characteristics of RAS-positive versus BRAF-positive Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Sep 30:jc20162620.
    PubMed     Text format     Abstract available


  54. XU JY, Murphy WA Jr, Milton DR, Jimenez C, et al
    Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Sep 23:jc20162815.
    PubMed     Text format     Abstract available


  55. KIM SW, Song SH, Lee HS, Noh WJ, et al
    Intraoperative Real-Time Localization of Normal Parathyroid Glands with Autofluorescence Imaging.
    J Clin Endocrinol Metab. 2016 Sep 20:jc20162558.
    PubMed     Text format     Abstract available


  56. CHEREAU N, Giudicelli X, Pattou F, Lifante JC, et al
    Diffuse sclerosing variant of papillary thyroid carcinoma is associated with aggressive histopathological features and a poor outcome: Results of a large multicentric study.
    J Clin Endocrinol Metab. 2016 Sep 14:jc20162341.
    PubMed     Text format     Abstract available


  57. UCHINO S, Ishikawa H, Miyauchi A, Hirokawa M, et al
    Age- and Gender-Specific Risk of Thyroid Cancer in Patients with Familial Adenomatous Polyposis.
    J Clin Endocrinol Metab. 2016 Sep 13:jc20162043.
    PubMed     Text format     Abstract available


    August 2016
  58. YU XU J, Handy B, Michaelis CL, Waguespack SG, et al
    Detection and Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Thyroid Cancer.
    J Clin Endocrinol Metab. 2016 Aug 30:jc20162567.
    PubMed     Text format     Abstract available


  59. TORREGROSSA L, Viola D, Sensi E, Giordano M, et al
    Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.
    J Clin Endocrinol Metab. 2016 Aug 29:jc20161775.
    PubMed     Text format     Abstract available


  60. ROBINSON B, Schlumberger M, Wirth LJ, Dutcus CE, et al
    Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer.
    J Clin Endocrinol Metab. 2016 Aug 22:jc20153989.
    PubMed     Text format     Abstract available


  61. CHOU CK, Chi SY, Huang CH, Chou FF, et al
    IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Aug 17:jc20162276.
    PubMed     Text format     Abstract available


  62. HOLLINGSWORTH B, Senter L, Zhang X, Brock GN, et al
    Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients.
    J Clin Endocrinol Metab. 2016 Aug 17:jc20161605.
    PubMed     Text format     Abstract available


  63. PALERMO A, Mangiameli G, Tabacco G, Longo F, et al
    PTH(1-34) for the primary prevention of post-thyroidectomy hypocalcemia: the THYPOS trial.
    J Clin Endocrinol Metab. 2016 Aug 15:jc20162530.
    PubMed     Text format     Abstract available


  64. LY S, Frates MC, Benson CB, Peters HE, et al
    Features and outcome of autonomous thyroid nodules in children: 31 consecutive patients seen at a single center.
    J Clin Endocrinol Metab. 2016 Aug 8:jc20161779.
    PubMed     Text format     Abstract available


  65. LABOURIER E
    Letter to the Editor: The Value of Molecular Testing for Effective Management of Patients With Indeterminate Thyroid Nodules.
    J Clin Endocrinol Metab. 2016;101:L76-7.
    PubMed     Text format    


    July 2016
  66. LIYANARACHCHI S, Li W, Yan P, Bundschuh R, et al
    Genome-wide expression screening discloses long noncoding RNAs involved in thyroid carcinogenesis.
    J Clin Endocrinol Metab. 2016 Jul 26:jc20161991.
    PubMed     Text format     Abstract available


  67. LUO J, Hendryx M, Manson JE, Liang X, et al
    Hysterectomy, oophorectomy and risk of thyroid cancer.
    J Clin Endocrinol Metab. 2016 Jul 26:jc20162011.
    PubMed     Text format     Abstract available


    May 2016
  68. LAMARTINA L, Grani G, Biffoni M, Giacomelli L, et al
    Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2016 May 17:jc20161440.
    PubMed     Text format     Abstract available


    April 2016
  69. LAMARTINA L, Ippolito S, Danis M, Bidault F, et al
    Anti-angiogenic Tyrosine Kinase Inhibitors: occurrence and risk factors of hemoptysis in refractory thyroid cancer.
    J Clin Endocrinol Metab. 2016 Apr 15:jc20154391.
    PubMed     Text format     Abstract available


  70. BASTMAN JJ, Serracino HS, Zhu Y, Koenig MR, et al
    Tumor-infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.
    J Clin Endocrinol Metab. 2016 Apr 5:jc20154227.
    PubMed     Text format     Abstract available


    March 2016
  71. MOMESSO DP, Vaisman F, Yang SP, Bulzico DA, et al
    DYNAMIC RISK STRATIFICATION IN DIFFERENTIATED THYROID CANCER PATIENTS TREATED WITHOUT RADIOACTIVE IODINE.
    J Clin Endocrinol Metab. 2016 Mar 29:jc20154290.
    PubMed     Text format     Abstract available


  72. BURCH HB, Burman KD, Cooper DS, Hennessey JV, et al
    A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules.
    J Clin Endocrinol Metab. 2016 Mar 25:jc20161155.
    PubMed     Text format     Abstract available


  73. KLEIN HESSELINK MS, Nies M, Bocca G, Brouwers AH, et al
    Pediatric differentiated thyroid carcinoma in the Netherlands: a nationwide follow-up study.
    J Clin Endocrinol Metab. 2016 Mar 10:jc20153290.
    PubMed     Text format     Abstract available


  74. KURIEN BT, Lane JT, Scofield RH
    Letter to the Editor: Getting to the True Values of Thyroglobulin and Anti-Thyroglobulin Antibodies.
    J Clin Endocrinol Metab. 2016;101:L38-9.
    PubMed     Text format    


  75. LATTEYER S, Klein-Hitpass L, Khandanpour C, Zwanziger D, et al
    A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A.
    J Clin Endocrinol Metab. 2016;101:1016-22.
    PubMed     Text format     Abstract available


  76. LADENSON PW
    Precision Medicine Comes to Thyroidology.
    J Clin Endocrinol Metab. 2016;101:799-803.
    PubMed     Text format     Abstract available


  77. LAZAR L, Lebenthal Y, Segal K, Steinmetz A, et al
    Pediatric thyroid cancer: postoperative classifications and response-to-initial-therapy as prognostic factors.
    J Clin Endocrinol Metab. 2016 Mar 1:jc20153960.
    PubMed     Text format     Abstract available


    February 2016
  78. AHN D, Ho Sohn J, Han Jeon J
    Hypothyroidism following hemithyroidectomy: incidence, risk factors, and clinical characteristics.
    J Clin Endocrinol Metab. 2016 Feb 22:jc20153997.
    PubMed     Text format     Abstract available


  79. BIKAS A, Schneider M, Desale S, Atkins F, et al
    Effects of Dosimetrically-Guided I-131 Therapy on Hematopoiesis in Patients with Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2016 Feb 22:jc20153544.
    PubMed     Text format     Abstract available


  80. YU Y, Zhang J, Lu G, Li T, et al
    Clinical relationship between IgG4-positive Hashimoto's thyroiditis and papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2016 Feb 11:jc20153783.
    PubMed     Text format     Abstract available


  81. FINKEL A, Liba L, Simon E, Bick T, et al
    Sub-clonality for BRAF mutation in papillary thyroid carcinoma is associated with earlier disease stage.
    J Clin Endocrinol Metab. 2016 Feb 2:jc20154031.
    PubMed     Text format     Abstract available


  82. ALVES TG, Kasamatsu TS, Yang JH, Meneghetti MC, et al
    Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay.
    J Clin Endocrinol Metab. 2016;101:653-8.
    PubMed     Text format     Abstract available


    January 2016
  83. YANG X, Liang J, Li T, Zhao T, et al
    Preablative stimulated thyroglobulin correlates to new therapy response system in differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2016 Jan 20:jc20154016.
    PubMed     Text format     Abstract available


  84. LUO J, Phillips L, Liu S, Wactawski-Wende J, et al
    Diabetes, diabetes treatment and risk of thyroid cancer.
    J Clin Endocrinol Metab. 2016 Jan 13:jc20153901.
    PubMed     Text format     Abstract available


  85. CHENG W, Liu R, Zhu G, Wang H, et al
    Robust Thyroid Gene Expression and Radioiodine Uptake Induced by Simultaneous Suppression of BRAF V600E and Histone Deacetylase in Thyroid Cancer Cells.
    J Clin Endocrinol Metab. 2016 Jan 11:jc20153433.
    PubMed     Text format     Abstract available


  86. NISHIMOTO K, Seki T, Kurihara I, Yokota K, et al
    Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
    J Clin Endocrinol Metab. 2016;101:6-9.
    PubMed     Text format     Abstract available


    November 2015
  87. SHI X, Liu R, Basolo F, Giannini R, et al
    Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    J Clin Endocrinol Metab. 2015 Nov 3:jc20152917.
    PubMed     Text format     Abstract available


    October 2015
  88. KWONG N, Medici M, Angell TE, Liu X, et al
    The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk.
    J Clin Endocrinol Metab. 2015 Oct 14:jc20153100.
    PubMed     Text format     Abstract available


    September 2015
  89. BIBLE KC, Cote GJ, Demeure MJ, Elisei R, et al
    Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group.
    J Clin Endocrinol Metab. 2015 Sep 29:jc20152818.
    PubMed     Text format     Abstract available


  90. ANGELL TE, Frates MC, Medici M, Liu X, et al
    Afirma Benign Thyroid Nodules Show Similar Growth to Cytologically Benign Nodules During Follow Up.
    J Clin Endocrinol Metab. 2015 Sep 9:jc20152658.
    PubMed     Text format     Abstract available


  91. AHN HY, Min HS, Yeo Y, Ma SH, et al
    Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer.
    J Clin Endocrinol Metab. 2015;100:3486-93.
    PubMed     Text format     Abstract available


    August 2015
  92. PACELLA CM, Mauri G, Achille G, Barbaro D, et al
    Outcomes and Risk Factors for Complications of Laser Ablation for Thyroid Nodules. A Multicenter Study on 1531 Patients.
    J Clin Endocrinol Metab. 2015 Aug 14:jc20151964.
    PubMed     Text format     Abstract available


  93. NETZEL BC, Grebe SK, Carranza Leon BG, Castro MR, et al
    Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.
    J Clin Endocrinol Metab. 2015;100:E1074-83.
    PubMed     Text format     Abstract available


    July 2015
  94. BELOUSOV PV, Bogolyubova AV, Kim YS, Abrosimov AY, et al
    Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1zeta Autoantibody As a Potential Biomarker in Thyroid Neoplasia.
    J Clin Endocrinol Metab. 2015 Jul 21:jc20144260.
    PubMed     Text format     Abstract available


  95. GIANI F, Vella V, Nicolosi ML, Fierabracci A, et al
    THYROSPHERES FROM NORMAL OR MALIGNANT THYROID TISSUE HAVE DIFFERENT BIOLOGIC, FUNCTIONAL AND GENETIC FEATURES.
    J Clin Endocrinol Metab. 2015 Jul 7:JC20144163.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: